Pharmafile Logo
Pharmafocus logo
Advanced Search

Silence Therapeutics

Showing 6 posts of 6 posts found.

partnership

AstraZeneca to leverage Silence Therapeutics’ siRNA expertise in $480mn deal

March 25, 2020
Research and Development, Sales and Marketing AstraZeneca, Silence Therapeutics, collaboration, pharma

Silence Therapeutics has revealed it has struck a new collaboration with AstraZeneca which will trigger the “acceleration and re-prioritisation of …

News
david_horn_solomon

Silence Therapeutics appoints ex-Akari CEO in top position

July 17, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akari, CEO, Sanofi, Silence Therapeutics, zealand

Silence Therapeutics has appointed Dr David Horn Solomon as its new Chief Executive Officer (CEO), effective immediately. Solomon will head …

Appointment
hoffman

Silence Therapeutics instate new COO

June 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, Silence Therapeutics

Silence Therapeutics, a company focused on developing medicines through the body’s natural mechanism of RNA interference, has appointed a new …

Appointment

Silence Therapeutics appoints chief medical adviser

September 19, 2012
Business Services, Research and Development, Sales and Marketing Michael Khan, Silence Therapeutics

Silence Therapeutics has announced the appointment of Michael Khan to its board of directors as chief medical adviser. Dr Khan …

Appointment

AstraZeneca extends siRNA collaboration

July 14, 2010
Research and Development AstraZeneca, RNA, Silence Therapeutics

AstraZeneca has agreed a one-year extension on its siRNA development collaboration with London-based Silence Therapeutics. Silence is a specialist in …

News

Silence Therapeutics promotes Jorg Kaufmann

May 21, 2010
Research and Development Silence Therapeutics, appointment, research and development, rnai

Jorg Kaufmann has been made vice president of research at UK biotech company Silence Therapeutics. He previously served as senior …

Appointment

Latest content

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024

Intra-Cellular Therapies shares phase 3 results for major depressive disorder therapy

April 17, 2024

Novartis shares new data about Fabhalta for IgAN treatment

April 16, 2024